Role of medication in the level of aluminium in the blood of chronic haemodialysis patients-Reference-Cited by-同舟云学术

Role of medication in the level of aluminium in the blood of chronic haemodialysis patients

Published:2008-11-21 Issue:4 Volume:24 Page:1277-1281
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Bohrer Denise,Bertagnolli Denise C.,de Oliveira Sandra M. R.,do Nascimento Paulo C.,de Carvalho Leandro M.,Garcia Solange C.,Arantes Luiz C.,Barros Elvino J. G.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/24/4/1277/17171357/gfn631.pdf

Reference16 articles.

1. Lanthanum: a safe phosphate binder;Persy;Semin Dial,2006

2. Sevelamer therapy for pediatric end-stage renal disease;Storms;Pharmacotherapy,2006

3. Control of hyperphosphatemia among patients with ESRD;Coladonato;J Am Soc Nephrol,2005

4. Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients;Kausz;Am J Kidney Dis,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyporesponsiveness to Erythropoietin-Stimulating Agents: Possible Solutions;Updates on Hemodialysis;2023-09-27

2. Trace elements, toxic metals, and metalloids in kidney disease;Nutritional Management of Renal Disease;2022

3. Guidance for the preparation and quality management of fluids for haemodialysis and related therapies—Part 1: General requirements;ANSI/AAMI/ISO 23500-1:2019; Preparation and quality management of fluids for haemodialysis and related therapies—Part 1: General requirements;2019-12-23

4. Association of Serum Aluminum Levels with Mortality in Patients on Chronic Hemodialysis;Scientific Reports;2018-11-13

5. Aluminum Toxicity: Evaluation of 16-Year Trend Among 14 919 Patients and 45 480 Results;Archives of Pathology & Laboratory Medicine;2018-03-06